Senseonics To Participate in Upcoming Institutional Investor Conferences
GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. NASDAQ:SENS a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.